- decreased circulating LDL cholesterol level / IMPC
- increased circulating calcium level / IMPC
- decreased body weight / IMPC
- decreased caudal vertebrae number / IMPC
- increased circulating triglyceride level / IMPC
- abnormal bone mineralization / IMPC
- thrombocytopenia / IMPC
- decreased lumbar vertebrae number / IMPC
- decreased sacral vertebrae number / IMPC
- increased lumbar vertebrae number / IMPC
- abnormal behavior / IMPC
- increased sacral vertebrae number / IMPC
129-Mta1tm1a(EUCOMM)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:04341 |
International strain name | 129-Mta1tm1a(EUCOMM)Wtsi/WtsiH |
Alternative name | EPD0002_2_B07 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Mta1tm1a(EUCOMM)Wtsi, |
Gene/Transgene symbol | Mta1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0002_2_B07. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (allele matching)
MGI phenotypes (allele matching)
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).